Compounds > 2-amino-7-phosphonoheptanoic acid
Page last updated: 2024-10-26

2-amino-7-phosphonoheptanoic acid and Central Nervous System Diseases

2-amino-7-phosphonoheptanoic acid has been researched along with Central Nervous System Diseases in 2 studies

2-amino-7-phosphonoheptanoic acid: (D)-isomer active as an antagonist of N-methyl-D-aspartate excitation of central neurons; (L)-isomer inactive; RN given refers to cpd without isomeric designation

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Millan, MH1
Wardley-Smith, B2
Halsey, MJ2
Meldrum, BS2
Rostain, JC1

Other Studies

2 other studies available for 2-amino-7-phosphonoheptanoic acid and Central Nervous System Diseases

ArticleYear
Effect of NMDA and 2-amino-7-phosphonoheptanoate focal injection into the ventrolateral thalamic nucleus on the high pressure neurological syndrome in the rat.
    Brain research, 1990, Jan-22, Volume: 507, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Aspartic Acid; Central Nervous System Diseases; H

1990
Effect of 2-aminophosphonoheptanoic acid on the EEG of rats exposed to high pressure.
    Undersea biomedical research, 1986, Volume: 13, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Atmospheric Pressure; Central Nervous System Dise

1986